Deciduous Therapeutics Is A Biotechnology Company Based In San Franciscocaliforniafounded In 2019The Company Is Dedicated To Developing Novel Medicines Aimed At Enhancing Human Health Span By Targeting Senescent Cellswhich Are Linked To Various Age Related Diseasestheir Mission Focuses On Positively Impacting Aging Through Innovative Therapeutic Solutions The Company Specializes In Creating Small Molecule Drugs And Monoclonal Antibodies That Activate The Immune System To Selectively Eliminate Senescent Cellsthis Approach Seeks To Improve Immune Surveillance And Reduce Inflammation And Tissue Damage Associated With Agingdeciduous Therapeutics Is Led By A Team Of Experienced Scientistsincluding Chief Scientific Officer Drchan Whitingwho Has Extensive Experience In Immunology And Drug Development With A Revenue Range Of $1 Million To $5 Milliondeciduous Therapeutics Operates With A Small Team Of 11 To 20 Employeesthe Company Is Also Associated With Y Combinator And Utilizes Various Technologies To Support Its Operations In The Biotechnology Sector
